Matthew James O'Neill,Chai Ann Ng,Takanori Aizawa,Luca Sala,Sahej Bains,Annika Winbo,Rizwan Ullah,Qianyi Shen,Chek-Ying Tan,Krystian Kozek,Loren Vanags,Devyn Mitchell,Alex Shen,Yuko Wada,Asami Kashiwa,Lia Crotti,Federica Dagradi,Giulia Musu,Raquel Neves,J. Martjin Bos,John Giudicessi,Xavier Bledsoe,Megan C Lancaster,Andrew Glazer,Dan M. Roden,Jochen Weile,Frederick Roth,Joe-Elie Salem,Nikki Earle,Rachael Stiles,Taylor Agee,Christopher Johnson,Minoru Horie,Jonathan Skinner,Michael J. Ackerman,Peter Schwartz,Seiko Ohno,Jamie Vandenberg,Brett Kroncke

Abstract:Background: Long QT syndrome (LQTS) is a lethal arrhythmia syndrome, frequently caused by rare loss-of-function variants in the potassium channel encoded by KCNH2. Variant classification is difficult, often owing to lack of functional data. Moreover, variant-based risk stratification is also complicated by heterogenous clinical data and incomplete penetrance. Here, we sought to test whether variant-specific information, primarily from high-throughput functional assays, could improve both classification and cardiac event risk stratification in a large, harmonized cohort of KCNH2 missense variant heterozygotes. Methods: We quantified cell-surface trafficking of 18,796 variants in KCNH2 using a Multiplexed Assay of Variant Effect (MAVE). We recorded KCNH2 current density for 533 variants by automated patch clamping (APC). We calibrated the strength of evidence of MAVE data according to ClinGen guidelines. We deeply phenotyped 1,458 patients with KCNH2 missense variants, including QTc, cardiac event history, and mortality. We correlated variant functional data and Bayesian LQTS penetrance estimates with cohort phenotypes and assessed hazard ratios for cardiac events. Results: Variant MAVE trafficking scores and APC peak tail currents were highly correlated (Spearman Rank-order correlation; = 0.69). The MAVE data were found to provide up to pathogenic very strong evidence for severe loss-of-function variants. In the cohort, both functional assays and Bayesian LQTS penetrance estimates were significantly predictive of cardiac events when independently modeled with patient sex and adjusted QT interval (QTc); however, MAVE data became non-significant when peak-tail current and penetrance estimates were also available. The area under the ROC for 20-year event outcomes based on patient-specific sex and QTc (AUC 0.80 [0.76-0.83]) was improved with prospectively available penetrance scores conditioned on MAVE (AUC 0.86 [0.83-0.89]) or attainable APC peak tail current data (AUC 0.84 [0.81-0.88]). Conclusion: High throughput KCNH2 variant MAVE data meaningfully contribute to variant classification at scale while LQTS penetrance estimates and APC peak tail current measurements meaningfully contribute to risk stratification of cardiac events in patients with heterozygous KCNH2 missense variants.

Spectrum and Prevalence of CALM1-, CALM2-, and CALM3-Encoded Calmodulin (CaM) Variants in Long QT Syndrome (LQTS) and Functional Characterization of a Novel LQTS-Associated CaM Missense Variant, E141G

Identification and Functional Characterization of a Novel CACNA1C -Mediated Cardiac Disorder Characterized by Prolonged QT Intervals with Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death

Clinical Aspects of Type-1 Long-Qt Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene.

Lqts Gene Lovd Database

Abstract 9741: A Novel Mutation Identified in a Large Multi-Generational Family With Long QT Syndrome Reveals Distinct, Disease-Specific Mutation Hot Spots within the <i>CACNA1C-</i> Encoded L-type Calcium Channel

Clinical interpretation of KCNH2 variants using a robust PS3/BS3 functional patch-clamp assay

Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome.

Identification of A Kir3.4 Mutation in Congenital Long Qt Syndrome

Utilization of the Genome Aggregation Database, in Silico Tools, and Heterologous Expression Patch Clamp Studies to Identify and Demote Previously Published Type 2 Long QT Syndrome-Causative Variants from Pathogenic to Likely Benign.

Novel Compound Heterozygous Mutations in the KCNQ1 Gene Associated with Autosomal Recessive Long QT Syndrome (jervell and Lange‐Nielsen Syndrome)

Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current

Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.

Abstract 16901: Utilizing in Silico Pathogenicity Prediction Tools and Heterologous Expression Patch Clamp Studies to Identify Bona Fide Pathogenic KCNH2 Variants among Publically Available Exomes Derived from Subjects Without Evidence for Either Type 2 Long QT Syndrome or Type 1 Short QT Syndrome

Voltage Gated Calcium Channel Dysregulation May Contribute to Neurological Symptoms in Calmodulinopathies

Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.

A Pore-Localizing CACNA1C-E1115K Missense Mutation, Identified in a Patient with Idiopathic QT Prolongation, Bradycardia, and Autism Spectrum Disorder, Converts the L-type Calcium Channel into a Hybrid Nonselective Monovalent Cation Channel.

Abstract Sa906: Topological Distribution of KCNH2 Variants and Genotype-Phenotype Relationship in Patients with Long QT Syndrome

A Novel Splice Mutation of HERG in a Chinese Family with Long QT Syndrome.

Prognostic Value of Multiplexed Assays of Variant Effect and Automated Patch-clamping for KCNH2-LQTS Risk Stratification

Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome

PO-630-04 ELUCIDATION OF ALG10B AS A NOVEL LONG QT SYNDROME SUSCEPTIBILITY GENE